Probenecid is a synthetic pharmaceutical compound belonging to the sulfonamide and benzoic acid derivative families. It is primarily classified as a uricosuric agent and is used in pharmaceutical formulations designed to manage hyperuricaemia associated with chronic gout.
Probenecid works by inhibiting the reabsorption of uric acid in the proximal renal tubules of the kidneys. This increases the urinary excretion of uric acid and helps reduce uric acid concentrations in the blood.
Probenecid is also known for its ability to inhibit the renal tubular secretion of certain organic acids and medications, including selected penicillin antibiotics. This property can increase the plasma concentrations and duration of action of certain medicines when used under appropriate medical supervision.
Probenecid has the molecular formula C₁₃H₁₉NO₄S and a molecular weight of approximately 285.36 g/mol. It is generally available as a white or almost white crystalline powder.
Probenecid IP refers to material intended to meet the applicable Indian Pharmacopoeia requirements. Its exact pharmacopoeial compliance should be verified against the current applicable monograph and batch-specific Certificate of Analysis (COA).
Swapnroop Drugs and Pharmaceuticals (SDP) focuses on pharmaceutical ingredients and chemical product requirements. The 1 Kg Probenecid IP product listing is intended for pharmaceutical and industrial business enquiries.
Contact our team for product specifications, availability, packaging and commercial information.
Probenecid possesses a benzoic acid structure containing a dipropylsulfamoyl functional group. Its chemical characteristics make it useful in pharmaceutical manufacturing and research involving uricosuric agents.
Key reference properties include:
Note: Physical property values are reference characteristics, not guaranteed batch specifications. Confirm actual results against the applicable pharmacopoeial requirements and COA.
Probenecid is a uricosuric agent that acts on renal tubular transport mechanisms.
It inhibits the reabsorption of urate in the proximal renal tubules, increasing the amount of uric acid eliminated through urine.
Its pharmacological activity involves:
Probenecid is used as an active pharmaceutical ingredient in medicines prescribed for chronic gout management. It helps increase uric acid elimination through the kidneys.
Probenecid is used in pharmaceutical formulations intended to reduce elevated uric acid levels in selected patients with hyperuricaemia.
Probenecid is an established uricosuric agent used in the development and manufacture of oral pharmaceutical dosage forms.
Probenecid inhibits the renal tubular secretion of certain antibiotics, particularly penicillins. This can increase their plasma concentrations and prolong their exposure when used in appropriate clinical settings.
Probenecid is relevant to pharmaceutical research involving renal drug transport, organic anion transporters, uricosuric activity and drug interaction studies.
Probenecid is used in the development of pharmaceutical formulations, including oral tablets, with attention to solubility, dissolution, stability and formulation compatibility.
Probenecid raw material is evaluated through appropriate analytical procedures to establish identity, purity, assay and compliance with applicable quality requirements.
Probenecid quality should be evaluated according to the applicable Indian Pharmacopoeia monograph and current product specification.
Important quality parameters may include:
Pharmacopoeial Reference Information:
The BP 2025 / Ph. Eur. monograph for Probenecid specifies:
Important: These are BP/Ph. Eur. reference values, not confirmed IP API acceptance limits. Do not use them as proof of IP compliance. Verify the applicable current IP API monograph and batch-specific COA before publishing numerical acceptance limits.
Probenecid IP should be stored and handled according to its current Safety Data Sheet (SDS), applicable pharmacopoeial requirements and pharmaceutical manufacturing procedures.
Safety Note: Probenecid is a pharmacologically active medicine. It may cause hypersensitivity reactions, gastrointestinal effects and kidney-related complications in susceptible individuals. It should only be used under appropriate medical supervision and is not intended for self-medication.
Probenecid IP is listed in a 1 Kg product pack size for pharmaceutical and industrial business enquiries.
Packaging information:
Contact Swapnroop Drugs and Pharmaceuticals for current stock, packaging details, pricing and technical documentation.
Swapnroop Drugs and Pharmaceuticals (SDP) focuses on pharmaceutical ingredients and chemical product requirements through its product portfolio and customer-oriented approach.
We aim to support pharmaceutical and business customers with:
Contact our team to enquire about Probenecid IP specifications, availability, 1 Kg packaging and pricing.
Q1. What is Probenecid IP?
Probenecid is a pharmaceutical compound belonging to the uricosuric agent category. It is used in medicines designed to increase urinary uric acid excretion and manage chronic gout.
Q2. What is the CAS number of Probenecid?
The CAS Registry Number of Probenecid is 57-66-9.
Q3. What is the molecular formula of Probenecid?
The molecular formula of Probenecid is C₁₃H₁₉NO₄S.
Q4. What is the molecular weight of Probenecid?
The molecular weight of Probenecid is approximately 285.36 g/mol.
Q5. What is the appearance of Probenecid?
Probenecid is generally available as a white or almost white crystalline powder.
Q6. What is the mechanism of action of Probenecid?
Probenecid inhibits the reabsorption of uric acid in the renal tubules, increasing urinary uric acid excretion and helping reduce serum uric acid levels.
Q7. What are the major pharmaceutical applications of Probenecid?
Probenecid is primarily used in medicines for chronic gout and selected hyperuricaemia conditions. It also has applications in drug interaction and renal transport research.
Q8. Is Probenecid soluble in water?
Probenecid is practically insoluble in water. It is soluble in acetone and sparingly soluble in anhydrous ethanol.
Q9. What is the melting point of Probenecid?
The BP/Ph. Eur. reference melting range is approximately 197–202°C.
Q10. What is the pack size of Probenecid IP offered in this listing?
The listed product pack size is 1 Kg. Confirm current availability and packaging with SDP.
Q11. What quality tests are important for Probenecid?
Important quality parameters include identification, assay, related substances, loss on drying, residue on ignition and other tests specified in the applicable pharmacopoeial monograph.
Q12. How should Probenecid IP be stored?
Probenecid should be stored in tightly closed containers in a cool and dry environment, following the current SDS and product-specific storage recommendations.
Q13. How can I enquire about 1 Kg Probenecid IP from SDP?
You can contact Swapnroop Drugs and Pharmaceuticals through its official website for product specifications, availability, packaging, technical documentation and commercial enquiries.
For Probenecid IP product information, technical specifications, quality documentation, 1 Kg packaging and business enquiries, connect with Swapnroop Drugs and Pharmaceuticals (SDP).
Website: https://www.sdp.org.in/
| Parameter | Specification |
|---|---|
| Appearance | White or almost white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 95.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Heavy Metals | NMT 10 ppm |
| pH (1% Solution) | 5.5–7.5 |
| Melting Point | 197–202°C. |
| Solubility | Practically insoluble in water; soluble in acetone |